Lymphoma: all 5,624 studies
Page 42 of 57. Open to participants first (824), then studies with results posted, then the rest; newest registration first within each.
- An Observational Study of MabThera/Rituxan (Rituximab) Plus Chemotherapy As First-Line Treatment in Patients With Diffuse Large B-Cell Lymphoma or Follicular LymphomaCompletedNCT01340443
- Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell LymphomaCompletedNCT01336920Phase 1
- Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell LymphomaCompletedNCT01334502Phase 1
- IGEV Followed by Autologous Transplantation for Refractory or Relapsed Hodgkin LymphomaStatus unknownNCT01333605Phase 2
- Evolution of Cellular and Viral Resistance in HIV-infected Patients With LymphomaStatus unknownNCT01330342
- Rituximab and Autologous Effector Lymphocytes in Non-Hodgkin Follicular Lymphoma in Response to First Line ChemotherapyStatus unknownNCT01329354Phase 2
- A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin LymphomaCompletedNCT01328626Phase 1
- A Randomised Evaluation of Molecular Guided Therapy for Diffuse Large B-cell Lymphoma With BortezomibCompletedNCT01324596Phase 3
- Combination of Bortezomib, Fludarabine and Cyclophosphamide Treat Recurrent Mantle Cell LymphomaStatus unknownNCT01322776Phase 1/2
- A Study Of Panobinostat In Children With Refractory Hematologic MalignanciesCompletedNCT01321346Phase 1
- Comparison of Creatinine Clearance Calculation for Estimation of GFR in Patients Receiving HD MethotrexateCompletedNCT01319591
- Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing ChemotherapyTerminatedNCT01319526
- Administration of T Lymphocytes for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma (CART CD30)WithdrawnNCT01316146Phase 1
- BRIEF Bendamustine and Rituximab In Elderly FollicularTerminatedNCT01313611Phase 2
- Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With RituximabCompletedNCT01311232
- Ultrasonographic Differentiation Between Kikuchi's Disease and Lymphoma in Patients With Cervical LymphadenopathyStatus unknownNCT01310933
- A Phase 1 Study of Brentuximab Vedotin Given Sequentially and Combined With Multi-Agent Chemotherapy for CD30-Positive Mature T-Cell and NK-Cell NeoplasmsCompletedNCT01309789Phase 1
- Rituximab With or Without Lenalidomide in Treating Patients With Previously Untreated Follicular LymphomaTerminatedNCT01307605Phase 2
- Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin LymphomaStatus unknownNCT01307592Phase 2
- Use of Interim PET Scan to Modify Therapy in Advanced Hodgkin's Lymphoma in Order to Improve OutcomesCompletedNCT01304849Not applicable
- A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly PatientsCompletedNCT01303887Phase 3
- Lymphoma in the OrbitStatus unknownNCT01302912
- Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and EtoposideTerminatedNCT01300793Phase 1
- TXA127 in Enhancement of Engraftment in Adult Double Cord Blood TransplantationTerminatedNCT01300611Phase 1
- Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin (ESHAOx) for Refractory or Relapsed Hodgkin's Lymphoma (HL)Status unknownNCT01300156Phase 2
- AMG 319 Lymphoid Malignancy FIHCompletedNCT01300026Phase 1
- Bendamustine, Cytarabine, Etoposide and Melphalan (BeEAM) as Conditioning for Autologous Stem Cell Transplant (ASCT) in Aggressive Non Hodgkin's Lymphoma (NHL).CompletedNCT01296256Phase 2
- A Study of Escalating Doses of Polatuzumab Vedotin in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia and Polatuzumab Vedotin in Combination With Rituximab in Participants With Relapsed or Refractory B-Cell Non-Hodgkins LymphomaCompletedNCT01290549Phase 1
- Chemotherapy Plus Rituximab Combination for Adult Lymphoblastic Leukemia (B-ALL) and Burkitt's Non-Hodgkin LymphomaCompletedNCT01290120Phase 2
- Assessment of Blood Biomarkers by DNA Microarrays in Patients With Aggressive Lymphoma BMS_LyTransCompletedNCT01287923
- Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)CompletedNCT01284192Phase 1
- A Study of Escalating Doses of Romidepsin in Association With CHOP in the Treatment of Peripheral T-Cell LymphomasCompletedNCT01280526Phase 1/2
- Abbreviated R-CHOP in Completely Excised Stage I or II DLBCLStatus unknownNCT01279902Phase 2
- This Trial is a Prospective Observational Study of Newly Diagnosed Diffuse Large B Cell Primary Breast LymphomasTerminatedNCT01279772
- Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors Including LymphomasCompletedNCT01279603Phase 1
- R-ESHAP Followed by Autologous Transplantation for Refractory or Relapsed Diffused Large B-cell LymphomaStatus unknownNCT01278602Phase 2
- TREatment of degeNerative and Neoplastic Diseases With RituximabStatus unknownNCT01277172Phase 2/3
- Study of Carfilzomib and Vorinostat for Relapsed or Refractory LymphomaCompletedNCT01276717Phase 1
- Study of HCD122 (Lucatumumab) and Bendamustine Combination Therapy in CD40+ Rituximab-refractory Follicular LymphomaCompletedNCT01275209Phase 1
- Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or LymphomaCompletedNCT01273090Phase 1
- Nonmyeloablative Allogeneic TransplantCompletedNCT01272817Not applicable
- Screening for Coronary Artery Disease After Mediastinal IrradiationCompletedNCT01271127Not applicable
- The Impact of Rituximab in Patients With Primary Breast Diffuse Large B Cell Lymphoma (DLBCL)CompletedNCT01266668
- Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter PyloriCompletedNCT01264822
- A Safety and Efficacy Study of SB1518 for the Treatment of Advanced Lymphoid MalignanciesCompletedNCT01263899Phase 2
- Ofatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell LymphomasWithdrawnNCT01263418Phase 2
- Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancersCompletedNCT01254578Phase 1
- Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's LymphomaCompletedNCT01251107Phase 3
- Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)CompletedNCT01250223
- The Use of FDG-PET in Patient With Hodgkin Lymphoma: a Population Based Study From Northern ItalyCompletedNCT01248000
- A Study of MK-4827 for the Treatment of Mantle Cell Lymphoma (MK-4827-002)WithdrawnNCT01244009Phase 2
- An Early Phase I Study of IPdR Absorption, Metabolism, and Safety in Patients With Advanced Solid Tumors and LymphomasCompletedNCT01240577Phase 1
- Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological CancersStatus unknownNCT01240525Phase 2
- Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin LymphomaCompletedNCT01239875Early Phase 1
- Hybrid SPECT/CTCA for the Assessment of the Presence and Hemodynamic Significance of CAD in Asymptomatic Patients.Status unknownNCT01239446Not applicable
- A Phase II Study of Oral Panobinostat (LBH589) and Rituximab to Treat Diffuse Large B Cell Lymphoma (DLBCL)CompletedNCT01238692Phase 2
- Concomitant Chemo-radiotherapy Followed by MIDLE Chemotherapy in Stage I/II Extranodal NK/T-cell LymphomaCompletedNCT01238159Phase 2
- Obatoclax Mesylate, Rituximab, and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Non-Hodgkin LymphomaWithdrawnNCT01238146Phase 1/2
- A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma.CompletedNCT01237236Phase 1
- RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell LeukemiaWithdrawnNCT01236586Phase 1
- MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or LeukemiaCompletedNCT01231919Phase 1
- Whole-body Diffusion-weighted Magnetic Resonance Imaging for Staging and Treatment Prediction of LymphomaActive, not recruitingNCT01231269Not applicable
- Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's LymphomaCompletedNCT01230983Phase 3
- Radiotherapy in Primary Mediastinal LymphomaCompletedNCT01230008
- Risk of Fatigue in Adolescent and Young Adult Hodgkin Lymphoma PatientsCompletedNCT01228461
- Feasibility Study Of Adding Bortezomib to R-ICE Chemotherapy To Treat Relapsed/ Refractory Diffuse Large B-Cell LymphomaCompletedNCT01226849Phase 1
- A Study Evaluating the Safety, Tolerability and Pharmacokinetics of GDC-0917 Administered to Patients With Refractory Solid Tumors or LymphomaCompletedNCT01226277Phase 1
- A Study to Assess AFM13 in Patients With Hodgkin LymphomaCompletedNCT01221571Phase 1
- Dexamethasone, Ofatumumab and Bendamustine (DOT) First-line in Mantle-cell Lymphoma(MCL)Status unknownNCT01221103Phase 1/2
- Rituximab Maintenance Therapy for Marginal Zone B-cell Lymphoma (MZL)CompletedNCT01213095Phase 2
- Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)CompletedNCT01212380Phase 1
- Allogeneic Natural Killer (NK) Cell Therapy in Patients With Lymphoma or Solid TumorCompletedNCT01212341Phase 1
- Incidence of Hepatitis B Virus (HBV) Reactivation in HBsAg Negative/HBcAb Positive Lymphoma Patients Treated With RCHOPStatus unknownNCT01210287Phase 2/3
- A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's LymphomaCompletedNCT01209130Phase 1
- Prospective Cohort Study With Central Nervous System Evaluation in Diffuse Large B-cell LymphomaCompletedNCT01202448Not applicable
- Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell TransplantNo longer availableNCT01200017
- RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell LymphomasCompletedNCT01198665Phase 1/2
- Epidemiology of Burkitt Lymphoma in East Africa Children or Minors (EMBLEM)CompletedNCT01196520
- A Treatment-Option Protocol to Provide Brentuximab Vedotin to Eligible Patients Completing Studies SGN35-005 or C25001No longer availableNCT01196208
- Study of Ofatumumab and ESHAP for the Treatment of Hodgkin's LymphomaCompletedNCT01195766Phase 2
- Study of Mini-Chop Plus Ofatumumab To Treat Cd 20+ Diffuse Large B-Cell Lymphoma In Patients Aged Over 80 YearsCompletedNCT01195714Phase 2
- Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced TumoursWithdrawnNCT01194193Phase 1
- Study of KW-0761 in Subjects With CCR4-positive Peripheral T/NK-cell LymphomaCompletedNCT01192984Phase 2
- A Study of PNT2258 in Patients With Advanced Solid TumorsCompletedNCT01191775Phase 1
- Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHLTerminatedNCT01187810Phase 1
- Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic LeukemiaStatus unknownNCT01185886
- Rituximab Augmentation Following R-CHOP Induction Chemotherapy in Extremely Elderly Patients With Diffuse Large B Cell LymphomaStatus unknownNCT01181999Phase 2
- Lenalidomide Therapy In Previously Untreated, Advanced Stage Follicular LymphomaWithdrawnNCT01180569Phase 1/2
- Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell LymphomaStatus unknownNCT01178658Phase 2
- Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat B Cell Lymphoma Except for Diffuse Large B Cell LymphomaStatus unknownNCT01178645Phase 2
- Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related DisordersActive, not recruitingNCT01177527
- High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin LymphomaCompletedNCT01177371Phase 2
- A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or LymphomaCompletedNCT01171092Early Phase 1
- Bendamustine and Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Non-Hodgkin's Lymphoma (NHL)WithdrawnNCT01170052Phase 1/2
- A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell LymphomaCompletedNCT01169298Phase 1
- Study of Debio 0932 in Patients With Advanced Solid Tumours or LymphomaCompletedNCT01168752Phase 1
- Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin LymphomaWithdrawnNCT01165645Not applicable
- Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic CancerCompletedNCT01164709Phase 1
- A Prospective Observational Study to Evaluate the Quality of Life and the Costs in a Real Life Setting in Patients Who Are Treated With 90Y-ZevalinCompletedNCT01164696
- Multicenter Phase II Study to Evaluate the Clinical Activity and the Safety Profile of Everolimus in Marginal Zone B-cell Lymphomas (MZL)CompletedNCT01164267Phase 2